These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6358356)

  • 1. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
    Parham P
    J Immunol; 1983 Dec; 131(6):2895-902. PubMed ID: 6358356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-step purification of pepsin-derived monoclonal antibody fragments from crude murine ascitic fluids by ceramic hydroxyapatite high-performance liquid chromatography.
    Moro A; Yoshitake T; Ogawa T; Ichimura T
    J Biochem; 2008 Dec; 144(6):733-9. PubMed ID: 18835826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
    Rousseaux J; Rousseaux-Prévost R; Bazin H
    J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL; Thomas TM; Rylatt DB
    Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the F(ab')2 and Fab' fragments prepared from a mouse monoclonal insulin antibody.
    Diaz-Alonso JM; Kohnert KD; Witt S; Ziegler M
    Allerg Immunol (Leipz); 1990; 36(2):95-101. PubMed ID: 2118298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique features of monoclonal IgG2b in the cleavage reaction with pepsin.
    Sumii H; Tsutsui K; Hatsushika M; Inoue H; Tanabe G; Oda T
    Acta Med Okayama; 1989 Jun; 43(3):135-41. PubMed ID: 2504035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
    J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope.
    Terness P; Kohl I; Hübener G; Battistutta R; Moroder L; Welschof M; Dufter C; Finger M; Hain C; Jung M
    J Immunol; 1995 Jun; 154(12):6446-52. PubMed ID: 7539020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
    Covell DG; Barbet J; Holton OD; Black CD; Parker RJ; Weinstein JN
    Cancer Res; 1986 Aug; 46(8):3969-78. PubMed ID: 3731067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of F(ab')2 fragments from mouse IgG of various subclasses.
    Lamoyi E; Nisonoff A
    J Immunol Methods; 1983 Jan; 56(2):235-43. PubMed ID: 6402547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments.
    Demignot S; Garnett MC; Baldwin RW
    J Immunol Methods; 1989 Jul; 121(2):209-17. PubMed ID: 2503561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies.
    Young WW; Tamura Y; Wolock DM; Fox JW
    J Immunol; 1984 Dec; 133(6):3163-6. PubMed ID: 6386983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the proteolytic fragments of bovine colostral IgG1.
    Wie SI; Dorrington KJ; Froese A
    J Immunol; 1978 Jul; 121(1):98-104. PubMed ID: 78949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
    Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
    Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
    Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.